Minor structural modifications convert the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2005-01-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM049036IPMID 15715457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Critical Role for Eosinophils in Allergic Airways Remodeling

  2004cited by this paper
• Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability.

  2004cited by this paper
• Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils

  2004cited by this paper
• Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists.

  2004cited by this paper
• 11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils*

  2004cited by this paper
• Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor‐homologous molecule expressed on Th2 cells/DP2

  2004cited by this paper
• Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.

  2004cited by this paper
• Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells Activation in Vivo Increases Blood Leukocyte Counts and Its Blockade Abrogates 13,14-Dihydro-15-keto-prostaglandin D2-Induced Eosinophilia in Rats

  2003cited by this paper
• Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane derivatives.

  2003cited by this paper
• An Orally Bioavailable Small Molecule Antagonist of CRTH2, Ramatroban (BAY u3405), Inhibits Prostaglandin D2-Induced Eosinophil Migration in Vitro

  2003cited by this paper
• To respond or not to respond: T cells in allergic asthma

  2003cited by this paper
• Prostaglandin D2 Inhibits Airway Dendritic Cell Migration and Function in Steady State Conditions by Selective Activation of the D Prostanoid Receptor 1 1

  2003cited by this paper
• Therapeutic potential of thromboxane inhibitors in asthma

  2002cited by this paper
• Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1

  2002cited by this paper
• Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2

  2001cited by this paper
• Role of the Parasite-Derived Prostaglandin D2 in the Inhibition of Epidermal Langerhans Cell Migration during Schistosomiasis Infection

  2001cited by this paper
• Prostaglandin D2 as a mediator of allergic asthma.

  2000cited by this paper
• Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice.

  1998cited by this paper
• Inflammatory mediators of asthma: an update.

  1998cited by this paper
• Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.

  1997cited by this paper
• Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.

  1997cited by this paper
• BAY u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics.

  1996cited by this paper
• Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.

  1994cited by this paper
• Mediators of allergic rhinitis.

  1992cited by this paper
• BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro

  1991cited by this paper
• The Thromboxane Receptor Antagonist BAY u3405 Reverses Prostaglandin D2 (PGD2)‐Induced Bronchoconstriction in the Anaesthetised Guinea Pig

  1991cited by this paper
• BAY u3405 an antagonist of thromboxane A2‐ and prostaglandin D2‐induced bronchoconstriction in the guinea‐pig

  1991cited by this paper
• Allergic inflammation and its pharmacological modulation in asthma.

  1991cited by this paper
• Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer.

  1989cited by this paper
• Release of prostaglandin D2 into human airways during acute antigen challenge.

  1986cited by this paper
• Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.

  1982cited by this paper
• Increased production of prostaglandin D2 in patients with systemic mastocytosis.

  1980cited by this paper

• Prostanoid receptors in GtoPdb v.2025.3

  2025cites this paper
• DP2 receptor activity sensor suited for antagonist screening and measurement of receptor dynamics in real-time

  2024cites this paper
• p-Toluenesulfonic acid-promoted organic transformations for the generation of molecular complexity.

  2024cites this paper
• Cascade hydroarylation/Diels-Alder cycloaddition of alkynylindoles with electron-deficient alkynes and alkenes.

  2023cites this paper
• Design, Synthesis, and Optimization of Indole Acetic Acid Derivatives as Potent and Selective CRTH2 Receptor Antagonists: Discovery of ACT‐774312

  2023cites this paper
• Ramatroban-Based Analogues Containing Fluorine Group as Potential 18F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers

  2021influential citation
• Prostanoid receptors in GtoPdb v.2021.2

  2021cites this paper
• Aziridines and 2H-Azirines—Monocyclic

  2020cites this paper
• Are Aspirin and Apixaban Sufficient to Prevent Immunothrombosis in COVID-19?

  2020cites this paper
• Ramatroban as a Novel Immunotherapy for COVID-19

  2020cites this paper
• DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment

  2019cites this paper
• Prostanoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• A synthetic route to 1,4-disubstituted tetrahydro-β-carbolines and tetrahydropyranoindoles via ring-opening/Pictet-Spengler reaction of aziridines and epoxides with indoles/aldehydes.

  2019cites this paper
• Same Target, Different Therapeutic Outcome: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma.

  2019cites this paper
• Structures of the Human PGD2 Receptor CRTH2 Reveal Novel Mechanisms for Ligand Recognition.

  2018cites this paper
• Comparison of pro-adipogenic effects between prostaglandin (PG) D2 and its stable, isosteric analogue, 11-deoxy-11-methylene-PGD2, during the maturation phase of cultured adipocytes.

  2018cites this paper
• Structural basis for ligand recognition of the human thromboxane A2 receptor

  2018cites this paper
• A Synthetic Route to Chiral 1,4-Disubstituted Tetrahydro-β-Carbolines via Domino Ring-Opening Cyclization of Activated Aziridines with 2-Vinylindoles.

  2017cites this paper
• Investigational prostaglandin D2 receptor antagonists for airway inflammation

  2016cites this paper
• Methoxycarbonyl migration in 3-methylene-1,4-cyclohexadienes. An extension of the von Auwers rearrangement

  2016cites this paper
• Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties.

  2014cites this paper
• Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs

  2014cites this paper
• Expression of DP2 (CRTh2), a Prostaglandin D2 Receptor, in Human Mast Cells

  2014cites this paper
• Immune mechanisms that underpin early-life Chlamydia respiratory infection-induced chronic lung disease

  2014influential citation
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• Arylglyoxals in synthesis of heterocyclic compounds.

  2013cites this paper
• Th2 cytokine antagonists: potential treatments for severe asthma

  2013influential citation
• Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism.

  2012cites this paper
• PGH1, the Precursor for the Anti-Inflammatory Prostaglandins of the 1-series, Is a Potent Activator of the Pro-Inflammatory Receptor CRTH2/DP2

  2012cites this paper
• Use of libraries to access new chemical space: applications to CRTH2.

  2012cites this paper
• CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils.

  2012cites this paper
• Mechanism of the N-protecting group dependent annulations of 3-aryloxy alkynyl indoles under gold catalysis: a computational study.

  2012cites this paper
• Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis.

  2012cites this paper
• Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists.

  2012cites this paper
• Cyclocondensation Reactions between 2-Acyl-3-indoleacetic Acid Derivatives and Phenylglycinol: Enantioselective Synthesis of 1-Substituted Tetrahydro-β-carboline Alkaloids

  2012cites this paper
• Discovery of AMG 853, a CRTH2 and DP Dual Antagonist.

  2011cites this paper
• Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981.

  2011cites this paper
• Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.

  2011cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

  2011cites this paper
• Recent Advances in the Discovery and Development of CRTh2 Antagonists

  2011cites this paper
• Effects of DP and CRTH2 activation on osteoblast function

  2011cites this paper
• Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases.

  2011cites this paper
• Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist

  2011cites this paper
• Prostaglandin D₂ receptor CRTH2 antagonists for the treatment of inflammatory diseases.

  2011cites this paper
• Regiodivergent annulation of alkynyl indoles to construct spiro-pseudoindoxyl and tetrahydro-β-carbolines.

  2011cites this paper
• Cyclooxygenases and Prostaglandin Receptors

  2011cites this paper
• Benzodiazepinone Derivatives as CRTH2 Antagonists.

  2011cites this paper
• Novel CRTH2 antagonists: a review of patents from 2006 to 2009

  2010cites this paper
• Agents Acting on Prostanoid and Thromboxane Receptors

  2010cites this paper
• Basophils and Eosinophils

  2010cites this paper
• CRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases

  2010cites this paper
• DP2 receptor antagonists in development

  2010cites this paper
• The mRNA level of Charcot–Leyden crystal protein/galectin-10 is a marker for CRTH2 activation in human whole blood in vitro

  2010cites this paper
• Ethyl 2-(1,2,3,4-tetrahydrospiro[carbazole-3,2′-[1,3]dioxolan]-9-yl)acetate

  2009cites this paper
• Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis.

  2009cites this paper
• Designing hypothesis of some 2,4 -disubstituted-phenoxy acetic acid derivatives as a Crth2 receptor antagonist: A QSAR approach

  2009cites this paper
• 4-Fluoro-N-methyl-N-(1,2,3,4-tetrahydrocarbazol-3-yl)benzenesulfonamide

  2009cites this paper
• Prostanoid receptor antagonists: development strategies and therapeutic applications

  2009cites this paper
• Emerging Nonsteroidal Anti-Inflammatory Therapies Targeting Specific Mechanisms in Asthma and Allergy

  2009cites this paper
• QSAR study of 2,4-disubstituted phenoxyacetic acid derivatives as a CRTh2 receptor antagonists

  2009cites this paper
• Discovery and optimization of CRTH2 and DP dual antagonists.

  2009cites this paper
• The roles of the prostaglandin D2 receptors DP1 and CRTH2 in promoting allergic responses

  2008cites this paper
• Prostaglandin H 2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th 2 cells , CRTH 2

  2008cites this paper
• Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2

  2008cites this paper
• A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils

  2008cites this paper
• Synthesis and Pharmacological Properties of Fluorinated Prostanoids

  2008cites this paper
• Asthma and Chronic Obstructive Pulmonary Disease

  2007cites this paper
• Synthesis and in vitro evaluation of a selective antagonist and the corresponding radioligand for the prostaglandin D2 receptor CRTH2.

  2007cites this paper
• Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases

  2007cites this paper
• The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking1

  2007cites this paper
• Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation

  2007cites this paper
• A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst

  2007cites this paper
• The Role of Small- or Medium-Sized Enterprises in Drug Discovery

  2007cites this paper
• Agonist and Antagonist Effects of 15R-Prostaglandin (PG) D2 and 11-Methylene-PGD2 on Human Eosinophils and Basophils

  2007cites this paper
• 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists.

  2007cites this paper
• Trafficking Receptor, 2 The Role of the Prostaglandin D

  2007cites this paper
• On the Mechanism of Interaction of Potent Surmountable and Insurmountable Antagonists with the Prostaglandin D2 Receptor CRTH2

  2006influential citation
• Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation.

  2006cites this paper
• Emerging roles of DP and CRTH2 in allergic inflammation.

  2006cites this paper
• Targeting memory Th2 cells for the treatment of allergic asthma.

  2006cites this paper
• Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.

  2005cites this paper
• Ligands du recepteur crth2 utilises a des fins therapeutiques

  2005cites this paper
• Indole-based CRTH2 antagonists

  2005cites this paper
• Identification of Indole Derivatives Exclusively Interfering with a G Protein-Independent Signaling Pathway of the Prostaglandin D2 Receptor CRTH2

  2005cites this paper
• Identification of Determinants of Ligand Binding Affinity and Selectivity in the Prostaglandin D2 Receptor CRTH2*

  2005cites this paper